Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
基本信息
- 批准号:8518334
- 负责人:
- 金额:$ 47.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiogenesis InhibitorsAngiogenic FactorArchitectureBioavailableBlindnessBlood VesselsBlood capillariesComplexCuesCytoplasmic TailDevelopmentDiabetic RetinopathyDiseaseEndothelial CellsEnsureFigs - dietaryGanglion Cell LayerGrowthHistocompatibility TestingHydroxylationHypoxiaHypoxia Inducible FactorInner Plexiform LayerLeadLocationMediatingMembraneMethodsMissionMolecularNational Eye InstituteNerve FibersOxygenPathway interactionsPatternPattern FormationPolyubiquitinationPositioning AttributeProcessProcollagen-Proline DioxygenaseProtein IsoformsProteinsRegulationRetinaRetinalRetinopathy of PrematurityRoleShapesSignal PathwaySignal TransductionSourceSpecific qualifier valueStructureTertiary Protein StructureTestingTimeTissuesTranslatingTransmembrane DomainVascular Endothelial CellVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsVascular SystemVascularizationangiogenesisbHLH-PAS factor HLFcapillarydensitydesigneffective therapymulticatalytic endopeptidase complexnovelouter plexiform layeroverexpressionparacrinepreventrepairedretina blood vessel structureretinal angiogenesisretinal damagetherapeutic developmenttranscription factorvascular bedvasculogenesis
项目摘要
The retinal vasculature is prone to damages, leading to serious ocular diseases including loss of vision. While angiogenic therapies are being explored as potential treatments, a significant hurdle is our inability to control the three dimensional organization of the vascular network induced by angiogenic factors to ensure proper functioning of pharmacologically induced retinal vasculature. Thus, our long term objective is to unravel mechanisms that control the spatial organization of retinal vascular beds, and in particular to investigate how components of the hypoxia signaling pathway act as spatial cues to determine the direction and position of vascular growth in the retina. These studies will be carried out in three specific aims. Aim 1. Investigate roles of prolyl hydroxylase domain proteins in controlling retinal vascular pattern formation. PHDs negatively regulate the abundance of hypoxia inducible factors (HIFs), the latter of which are essential for angiogenesis. We hypothesize that the level of PHD activity in a tissue microenvironment determines the activity and directionality of vascular growth in its vicinity, and will test this hypothesis by generating chimeric retinas that contain micro tissue domains with PHD deficiency or overexpression. Aim 2. Determine if HIF-la accumulation in a micro tissue domain controls the position and direction of vascular growth in nearby tissues. Aim 3. Explore the role of VEGFR-l in defining vessel to vessel distances. VEGFR-l is produced by endothelial cells and forms tight complex with VEGF-A, a key angiogenic molecule induced by hypoxia. We propose that VEGF-A/VEGFR-1 interaction diminishes bioavailable VEGF-A near the source of VEGFR-l expression and therefore disallows the growth of more microvessels within a certain distance from an existing microvessel. This hypothesis will be tested by creating chimeric retinas that contain micro tissue domains overexpressing VEGFR-1, and assessing vascular density near such tissues. The objective of these studies is to facilitate the development of effective therapies aimed at repairing damaged retinal vascular beds and is highly consistent with the mission of the National Eye Institute (NEI).
视网膜脉管系统容易受到损害,导致严重的眼部疾病,包括视力丧失。尽管正在探讨血管生成疗法作为潜在疗法,但一个重大障碍是我们无法控制由血管生成因子诱导的血管网络的三维组织,以确保药理诱导的视网膜血管的正确功能。因此,我们的长期目标是阐明控制视网膜血管床的空间组织的机制,尤其是研究缺氧信号传导途径的成分如何作为确定视网膜血管生长方向和位置的空间提示。这些研究将以三个具体目标进行。目标1。研究丙酰羟化酶结构蛋白在控制视网膜血管模式形成中的作用。 PHD对低氧诱导因子(HIF)的丰度负调节,后者对于血管生成至关重要。我们假设组织微环境中的PHD活性水平决定其附近血管生长的活性和方向性,并通过产生包含具有PHD缺乏或过表达的微组织结构域的嵌合视网膜来检验该假设。 AIM 2。确定HIF-LA在微组织结构域中积累是否控制附近组织中血管生长的位置和方向。 AIM 3。探索VEGFR-L在将血管定义为容器距离方面的作用。 VEGFR-L由内皮细胞产生,并与VEGF-A形成紧密复合物,VEGF-A是由缺氧诱导的关键血管生成分子。我们建议VEGF-A/VEGFR-1相互作用在VEGFR-L表达来源附近降低了可生物可利用的VEGF-A,因此不允许在与现有微血管一定距离内的更多微量花序的生长。该假设将通过创建包含过表达VEGFR-1的微组织结构域并评估此类组织附近的血管密度的嵌合视网膜来检验。这些研究的目的是促进旨在修复损坏的视网膜血管床的有效疗法的开发,并且与国家眼科研究所(NEI)的任务高度一致。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guo-Hua Fong其他文献
Guo-Hua Fong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guo-Hua Fong', 18)}}的其他基金
The Oxygen Sensing Mechanism in Retinal Endothelial Cells as a Novel Target to Suppress Ischemic Neovascularization
视网膜内皮细胞的氧传感机制作为抑制缺血性新生血管的新靶点
- 批准号:
10653006 - 财政年份:2020
- 资助金额:
$ 47.1万 - 项目类别:
The Oxygen Sensing Mechanism in Retinal Endothelial Cells as a Novel Target to Suppress Ischemic Neovascularization
视网膜内皮细胞的氧传感机制作为抑制缺血性新生血管的新靶点
- 批准号:
10436853 - 财政年份:2020
- 资助金额:
$ 47.1万 - 项目类别:
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
通过氧传感机制调节视网膜血管生成和血管完整性
- 批准号:
9752547 - 财政年份:2009
- 资助金额:
$ 47.1万 - 项目类别:
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
通过氧传感机制调节视网膜血管生成和血管完整性
- 批准号:
8964228 - 财政年份:2009
- 资助金额:
$ 47.1万 - 项目类别:
A novel technology to generate conditionally inactivated alleles in mice
一种在小鼠体内产生条件失活等位基因的新技术
- 批准号:
7315988 - 财政年份:2007
- 资助金额:
$ 47.1万 - 项目类别:
A novel technology to generate conditionally inactivated alleles in mice
一种在小鼠体内产生条件失活等位基因的新技术
- 批准号:
7471453 - 财政年份:2007
- 资助金额:
$ 47.1万 - 项目类别:
相似国自然基金
血管生成抑制剂通过肿瘤相关高内皮静脉调控三阴乳腺癌三级淋巴结构成熟的机制研究
- 批准号:82373278
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于不对称双-β-咔啉骨架的血管生成抑制剂的设计、合成及活性研究
- 批准号:
- 批准年份:2020
- 资助金额:40 万元
- 项目类别:地区科学基金项目
免疫检查点抑制剂联合抗血管生成治疗肝癌协同机制的定量磁共振研究
- 批准号:82001786
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
抗血管生成抑制乳腺癌生长转移的作用机制及其靶向抑制剂研究
- 批准号:81911530168
- 批准年份:2019
- 资助金额:40 万元
- 项目类别:国际(地区)合作与交流项目
凝血酶抑制剂对肺癌血管生成拟态形成的抑制作用及分子机制研究
- 批准号:81902995
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health
产后强化抗高血压治疗可改善女性心血管健康
- 批准号:
10664483 - 财政年份:2023
- 资助金额:
$ 47.1万 - 项目类别:
Bile acid receptor signaling in retinopathy of prematurity
早产儿视网膜病变中胆汁酸受体信号传导
- 批准号:
10568100 - 财政年份:2023
- 资助金额:
$ 47.1万 - 项目类别:
Molecular Engineering of Novel Therapies to Treat Corneal Neovascularization
治疗角膜新生血管的新疗法的分子工程
- 批准号:
10592879 - 财政年份:2023
- 资助金额:
$ 47.1万 - 项目类别:
Clinical and functional follow-up of maternal and fetal preeclampsia genetic risk loci
母婴子痫前期遗传风险位点的临床和功能随访
- 批准号:
10660975 - 财政年份:2022
- 资助金额:
$ 47.1万 - 项目类别: